← Back to Search

Speech Tasks for Speech Perception

N/A
Waitlist Available
Led By Edward F Chang, MD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Participants who lack capacity or decline to provide informed consent
Participants with cognitive deficits that preclude reliable completion of study tasks
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during procedure
Awards & highlights
No Placebo-Only Group

Summary

This trial is investigating how the brain extracts linguistic elements from speech sounds in order to better understand and treat human language disorders.

Who is the study for?
This trial is for individuals at UCSF with epilepsy or brain tumors who are undergoing surgical electrode implantation. They must have electrodes in at least two key brain areas and be able to perform study tasks. Those unable to consent, with significant cerebral lesions, or cognitive deficits that prevent task completion cannot participate.
What is being tested?
The study investigates how the superior temporal gyrus of the brain processes speech sounds. Participants will perform speech tasks while their brain activity is monitored to understand how we perceive words and continuous speech, aiming to improve language disorder treatments.
What are the potential side effects?
Since this trial involves non-invasive speech tasks without drugs or medical procedures beyond those already required for participants' clinical care, there are no direct side effects from the interventions being studied.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am unable or unwilling to give consent for this trial.
Select...
I am able to understand and complete study tasks despite any cognitive issues.
Select...
I have significant brain lesions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during procedure
This trial's timeline: 3 weeks for screening, Varies for treatment, and during procedure for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Number of Participants with Electrocorticography (ECoG) Signals for Neural Activity Identified During Intraoperative Procedure or Inpatient Hospitalization

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Electrocorticography (ECoG) recording during Speech TasksExperimental Treatment1 Intervention
Participants listened to 25-minute Speech Tasks while ECoG signals for neural activity was recorded during their intraoperative procedure or inpatient hospitalization at the University of California, San Francisco (UCSF).

Find a Location

Who is running the clinical trial?

University of California, San FranciscoLead Sponsor
2,590 Previous Clinical Trials
14,901,343 Total Patients Enrolled
2 Trials studying Speech
82 Patients Enrolled for Speech
National Institute on Deafness and Other Communication Disorders (NIDCD)NIH
354 Previous Clinical Trials
181,675 Total Patients Enrolled
15 Trials studying Speech
1,991 Patients Enrolled for Speech
University of California, BerkeleyOTHER
187 Previous Clinical Trials
640,889 Total Patients Enrolled
1 Trials studying Speech
52 Patients Enrolled for Speech
Edward F Chang, MDPrincipal InvestigatorUniversity of California, San Francisco
3 Previous Clinical Trials
182 Total Patients Enrolled
2 Trials studying Speech
82 Patients Enrolled for Speech

Media Library

Speech Tasks Clinical Trial Eligibility Overview. Trial Name: NCT05435859 — N/A
Speech Research Study Groups: Electrocorticography (ECoG) recording during Speech Tasks
Speech Clinical Trial 2023: Speech Tasks Highlights & Side Effects. Trial Name: NCT05435859 — N/A
Speech Tasks 2023 Treatment Timeline for Medical Study. Trial Name: NCT05435859 — N/A
~32 spots leftby Jul 2027